- 全部删除
您的购物车当前为空
Navitoclax-piperazine (ABT-263-piperazine) 是一种特大型 B 细胞淋巴瘤(BCL-XL)抑制剂。它和 E3 泛素连接酶的 VHL 配体可用来合成 PROTAC DT2216。


为众多的药物研发团队赋能,
让新药发现更简单!
Navitoclax-piperazine (ABT-263-piperazine) 是一种特大型 B 细胞淋巴瘤(BCL-XL)抑制剂。它和 E3 泛素连接酶的 VHL 配体可用来合成 PROTAC DT2216。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 521 | In stock | |
| 5 mg | ¥ 1,290 | In stock | |
| 10 mg | ¥ 2,080 | In stock | |
| 25 mg | ¥ 3,330 | In stock | |
| 50 mg | ¥ 4,530 | In stock | |
| 100 mg | ¥ 5,920 | In stock | |
| 200 mg | ¥ 8,220 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,230 | In stock |
Navitoclax-piperazine 相关产品
| 产品描述 | Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL). |
| 别名 | ABT-263-piperazine |
| 分子量 | 973.63 |
| 分子式 | C47H56ClF3N6O5S3 |
| CAS No. | 2143096-93-7 |
| Smiles | CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCNCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1 |
| 密度 | 1.41 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 250 mg/mL (256.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容